Alcon, a global eye care company known for products such as Systane and GenTeal Tears, plans to launch Tryptyr in the U.S. market in the third quarter of 2025. International rollouts are expected to ...

The active ingredient in Tryptyr is acoltremon, an agonist of transient receptor potential melastatin 8 thermoreceptors.

The FDA approved Tryptyr to treat the signs and symptoms of dry eye disease, according to a press release from Alcon. Tryptyr ...

Six years after being spun out from Novartis and becoming a public company, eye care specialist Alcon has gained its first ...

Spun off from Novartis in 2019, Alcon is betting on new product launches to accelerate sales growth in the second half of ...

All eye drop users should check out the FDA's list of 26 different eye drops that could cause infection or even blindness. The FDA has reported that Velocity Pharma manufactured its eye drops under ...

If you currently have eye drops in your medicine cabinet, make sure they're not part of a recent recall. Plus, how to buy ...

AvKare did not specify what issues had been identified. The five recalled products include lubricant eye drops and eye gels, which consumers should immediately cease using, AvKare warned.

AvKare did not specify what issues had been identified. The five recalled products include lubricant eye drops and eye gels, which consumers should immediately cease using, AvKare warned. The items ...

Over 75,000 bottles of eye drops have been recalled due to FDA audit findings of manufacturing violations, including sterility concerns. AvKare, the manufacturer of the affected products, stated the ...